Zobrazeno 1 - 10
of 128
pro vyhledávání: '"D Yu Belousov"'
Publikováno v:
Терапевтический архив, Vol 88, Iss 9, Pp 39-49 (2016)
Aim. Clinical and economic examinations were made to study whether it is appropriate to use antiplatelet therapy (APT) with ticagrelor in combination with acetylsalicylic acid (ASA) versus a combination of clopidogrel and ASA in patients with acute c
Externí odkaz:
https://doaj.org/article/6a2f82f697ec4387aaf65617386309a0
Publikováno v:
Системные гипертензии, Vol 12, Iss 3, Pp 11-18 (2015)
Group of researchers analytical group of PIFAGOR IV study The aim is to study the next step of pharmacoepidemiology of arterial hypertension (AH) in Russia to evaluate the structure and frequency of different classes of antihypertensive drugs (AHD) u
Externí odkaz:
https://doaj.org/article/5752c33965be4cbda955162846f49cfb
Publikováno v:
Системные гипертензии, Vol 7, Iss 2, Pp 33-39 (2010)
Externí odkaz:
https://doaj.org/article/f229fce47a9b47df8d7bbea0d4aa798a
Publikováno v:
Сахарный диабет, Vol 12, Iss 2, Pp 63-66 (2009)
Aim. To assess expedience of metformin combination with long-acting insulin, determine optimal doses of metformin for patients with type 2 diabetesmellitus (DM2), and accomplish pharmacoeconomic analysis of clinical efficiency of various therapeutic
Externí odkaz:
https://doaj.org/article/dbec75fcad3644aea6b212d3ed27879b
Autor:
A. E. Cheberda, D. Yu. Belousov
Publikováno v:
Качественная клиническая практика, Vol 0, Iss 4, Pp 96-107 (2024)
Aim. To assess the efficacy profiles of different dosing regimens of tofacitinib, baricitinib, and upadacitinib — novel selective oral Janus activated kinase inhibitors, in rheumatoid arthritis (RA). Materials and methods. Randomized controlled tri
Externí odkaz:
https://doaj.org/article/17035698925941c8bfee596dca472743
Autor:
A. S. Motrinchuk, D. Yu. Belousov
Publikováno v:
Реальная клиническая практика: данные и доказательства, Vol 3, Iss 4, Pp 29-40 (2023)
This guidance provides recommendations to sponsors and investigators considering the use of externally controlled clinical trials to provide evidence of the safety and effectiveness of a drug product. In an externally controlled trial, outcomes in pa
Externí odkaz:
https://doaj.org/article/c3f1607c639e48b5bfc7df65bf70dd0e
Publikováno v:
Качественная клиническая практика, Vol 0, Iss 3, Pp 15-28 (2023)
The review is focused on discussing new trends in DM, rethinking the evidence base medicine with an emphasis on demonstrating the efficacy and safety of new therapeutic agents and medical technologies, from gene editing to AI algorithms. At the same
Externí odkaz:
https://doaj.org/article/e3dfe2a378ba4038ae57b07b025df8a2
Publikováno v:
Реальная клиническая практика: данные и доказательства, Vol 2, Iss 2, Pp 41-44 (2022)
This article is devoted to an ethical review of planned real-world studies. The legal basis of such examinations has also been considered. Most real-world studies are non-interventional, so the ethical review of such studies is similar to that of obs
Externí odkaz:
https://doaj.org/article/c765c816752c439398438165c5c47592
Autor:
D. Yu. Belousov
Publikováno v:
Качественная клиническая практика, Vol 0, Iss 1 (2023)
Externí odkaz:
https://doaj.org/article/2035469cf87f4176ba03d1302f2edfef
Autor:
A. S. Kolbin, D. Yu. Belousov
Publikováno v:
Реальная клиническая практика: данные и доказательства, Vol 2, Iss 1, Pp 1-9 (2022)
The article provides a brief overview of the main trends in the development of real-world data and real-world evidence (RWD/RWE) paradigm in the United States, Russia, and the Eurasian Economic Union (EAEU) in 2021. The review is compiled in calendar
Externí odkaz:
https://doaj.org/article/e11f6e9f19e5469a9603c725a724092c